| 000 | 01744cam a2200337 a 4500 | ||
|---|---|---|---|
| 003 | EG-GiCUC | ||
| 005 | 20250223030520.0 | ||
| 008 | 111122s2011 ua d f m 000 0 eng d | ||
| 040 |
_aEG-GiCUC _beng _cEG-GiCUC |
||
| 041 | 0 | _aeng | |
| 049 | _aDeposite | ||
| 097 | _aM.Sc | ||
| 099 | _aCai01.11.33.M.Sc.2011.Ah.A | ||
| 100 | 0 | _aAhmed Ibrahim Abushadi | |
| 245 | 1 | 0 |
_aAssessment of health related quality of life in patients receiving stem cell therapy for end stage liver disease / _cAhmed Ibrahim AbuShadi ; Supervised Hosny Mohamed Salama , Rasha Ahmed Abdalaziz |
| 246 | 1 | 5 | _aتقييم نوعيه الحياة الصحية في مرضى الفشل الكبدى المتقدم المعالجون بالخلايا الجذعية |
| 260 |
_aCairo : _bAhmed Ibrahim AbuShadi , _c2011 |
||
| 300 |
_a262 P. : _bcharts ; _c25cm |
||
| 502 | _aThesis (M.Sc.) - Cairo University - Faculty of Medicine - Department of Tropical Medicine | ||
| 520 | _aEnd stage liver disease is the final stage of acute or chronic liver damage and is irreversibly associated with liver failure. End stage liver disease can develop rapidly, over days or weeks (acute and sub-acute liver failure, respectively), or gradually, over months or years (chronic liver failure). Currently, liver transplantation is the most effective therapy for patients with end stage liver disease | ||
| 530 | _aIssued also as CD | ||
| 653 | 4 | _aHealth related quality of life | |
| 653 | 4 | _aLiver cirrhosis | |
| 653 | 4 | _aStem cell therapy | |
| 700 | 0 |
_aHosny Mohamed Salama , _eSupervisor |
|
| 700 | 0 |
_aRasha Ahmed Abdalaziz , _eSupervisor |
|
| 856 | _uhttp://172.23.153.220/th.pdf | ||
| 905 |
_aNazla _eRevisor |
||
| 905 |
_aSamia _eCataloger |
||
| 942 |
_2ddc _cTH |
||
| 999 |
_c36319 _d36319 |
||